for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BUZZ-Second Sight Medical Products: Retinal device gets Heath Canada approval

** Medical device maker’s shares up 8 pct at $11.74

** Receives Health Canada’s approval for retinal implants to treat patients with outer retinal degeneration

** Company’s Argus II Retinal Prosthesis is an electronic implant designed to improve vision in those with severe cases of the inherited disease

** Outer retinal degeneration is caused by progressive death of the cells in the region

** Argus II Retinal Prosthesis already approved in U.S.

** Up to Friday’s close, stock had risen 20 pct since its debut on Nov. 19

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up